WEBINAR The New Frontier for Claims: The Disease-ification of Anxiety, Mood & Sleep
Join us live Wednesday, September 15th at 2:00 pm ET
The COVID pandemic has caused consumers to pay even more attention to their own mental wellbeing—sleep, relaxation, how they handle stress and anxiety, energy and focus, even mental sharpness. All signs point to substantial market opportunities for dietary supplements in these categories.
At the same time, FDA is closely scrutinizing supplement claims in these areas. And some retailers and online platforms are imposing their own limitations on these claims. If pharma companies succeed in “disease-ifying” the conditions as more than responses to everyday life, structure/functions claims could get recast as disease claims instead. What claims can marketers make for the collection of mental being claims?
This cutting edge webinar will explore:
· Market overview of consumer interest in mental wellbeing
· Recent FDA enforcement for impermissible mental health claims
· Recent research on ingredients with benefits for stress, relaxation and mood
· Best practices for navigating claims restrictions in this area
· Unique challenges for designing clinical trials to demonstrate mental wellbeing benefits
Don’t miss this opportunity to relieve your stress and sharpen your focus on this fast growing category!
Cost: $99 for CRN members; $149 for non-members | 
